WitrynaIMMUCOR, INC. FDA.report › GUDID › IMMUCOR, INC. › 10888234001812. Low ionic-strength salt solution (LISS) immunohaematology reagent IVD Low ionic-strength salt solution (LISS) immunohaematology reagent IVD Low ionic-strength salt solution (LISS) immunohaematology reagent IVD Low ionic-strength salt solution ... WitrynagGuard® Communication Software. Automatically collects and records hood data, alerts and alarms on a customer-supplied personal computer; Monitors, manages and provides data via email to a designated facility manager
FMH RapidScreen 0007893 Medical Device Identification
WitrynaFrom the routine ABO to a monoclonal Anti-P1 and rare lectins. An extensive offering of AHG reagents from basic to complex with a choice of package sizes and clear or green reagent dye to improve process controls in your laboratory. Assays may include antibody screening, antibody identification, Weak D testing, antiglobulin crossmatch and rare ... WitrynaOnly one company offers the most comprehensive range of reagents for every size laboratory, both manual and automated. And only one company is solely focused on the needs and challenges of the blood bank. Only Immucor Gamma. The world leader. Reagent Red Blood Cells. Blood Grouping Reagents. Anti-Human Globulin. … how to reuse jeans
US Products Quotient
WitrynaCompany Name: IMMUCOR, INC. Primary DI Number: 10888234000235. Issuing Agency: GS1. Commercial Distribution End Date: NA. Device Count: 1. Device Description: Bovine Albumin Solution 22% is intended for use as a high protein potentiator in crossmatch, antibody identification and antibody titration procedures. Witrynaleast one reagent where agglutination strength at IS was generally in the weak (w+) -≤2+ range; 5 samples showed positive reactivity (w+-≤2+) with 3 or more reagents; 5 samples had variable reactivity (0- 4+) with all six reagents; 1 sample showed strong positive reactivity (3-4+) with all WitrynaThe instrument was designed to use Immucor's proprietary Capture reagent product technology. In July 1993, the company announced that its year-end net income had fallen to $1.83 million compared to $3.04 million in 1992. Due to research and development costs on the ABS2000, and shrinking European profits, the company also declared a … northeast pa healthcare coalition